文献速递免疫规划传染病防控与疫情报告

基于磁性硫酸化纤维素颗粒的细胞培养全病毒甲型流感疫苗可保护小鼠抵抗致死性甲型流感病毒感染

A cell culture-derived whole virus influenza A vaccine based on magnetic sulfated cellulose particles confers protection in mice against lethal influenza A virus infection.
PubMed 文献 · Vaccine · 2016-11-02

研究建立基于磁性颗粒的全病毒颗粒纯化与配制平台,用悬浮MDCK细胞生产的甲型流感病毒颗粒结合磁性硫酸化纤维素颗粒(MSCP)直接免疫小鼠。与模拟免疫组相比,抗原负载MSCP(aMSCP)免疫组产生高抗甲型流感抗体应答,并对致死性甲型流感病毒攻击提供完全保护。

要点

  • aMSCP免疫小鼠产生高抗甲型流感抗体应答。
  • aMSCP免疫小鼠对致死性甲型流感病毒攻击获得完全保护。
  • aMSCP免疫小鼠肺内流感核蛋白基因拷贝数较模拟组减少400倍。

核心结论

  • MSCP用于流感疫苗纯化与配制快速高效,并能保护小鼠抵抗甲型流感病毒感染。

研究设计与样本

  • 概念验证研究:以悬浮MDCK细胞生产的甲型流感病毒颗粒经澄清、灭活、浓缩、渗滤后结合MSCP,直接免疫小鼠并设阳性与阴性对照。

主要发现

  • aMSCP免疫组产生高抗甲型流感抗体应答,模拟免疫组无此应答。
  • aMSCP免疫组对致死性复制 competent 甲型流感病毒攻击获得完全保护。
  • aMSCP免疫小鼠肺内流感核蛋白基因拷贝数较模拟处理动物减少400倍。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Downstream processing and formulation of viral vaccines employs a large number of different unit operations to achieve the desired product qualities. The complexity of individual process steps involved, the need for time consuming studies towards the optimization of virus yields, and very high requirements regarding potency and safety of vaccines results typically in long lead times for the establishment of new processes. To overcome such obstacles, to enable fast screening of potential vaccine candidates, and to explore options for production of low cost veterinary vaccines a new platform for whole virus particle purification and formulation based on magnetic particles has been established. Proof of concept was carried out with influenza A virus particles produced in suspension Madin Darby canine kidney (MDCK) cells. The clarified, inactivated, concentrated, and diafiltered virus particles were bound to magnetic sulfated cellulose particles (MSCP), and directly injected into mice for immunization including positive and negative controls. We show here, that in contrast to the mock-immunized group, vaccination of mice with antigen-loaded MSCP (aMSCP) resulted in high anti-influenza A antibody responses and full protection against a lethal challenge with replication competent influenza A virus. Antiviral protection correlated with a 400-fold reduced number of influenza nucleoprotein gene copies in the lungs of aMSCP immunized mice compared to mock-treated animals, indicating the efficient induction of antiviral immunity by this novel approach. Thus, our data proved the use of MSCP for purification and formulation of the influenza vaccine to be fast and efficient, and to confer protection of mice against influenza A virus infection. Furthermore, the method proposed has the potential for fast purification of virus particles directly from bioreactor harvests with a minimum number of process steps towards formulation of low-cost veterinary vaccines, and for screening studies requiring fast purification protocols.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Pieler MM, Frentzel S, Bruder D, et al. A cell culture-derived whole virus influenza A vaccine based on magnetic sulfated cellulose particles confers protection in mice against lethal influenza A virus infection. Vaccine. 2016. PMID: 27816372. doi:10.1016/j.vaccine.2016.10.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。